These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20740682)

  • 41. [Adsorption of antigens K88 and K99 on aluminum hydroxide gel].
    Kapurdova M; Petkov M; Marchev N
    Vet Med Nauki; 1987; 24(1):15-8. PubMed ID: 3303654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials.
    Leroux-Roels I; Devaster JM; Leroux-Roels G; Verlant V; Henckaerts I; Moris P; Hermand P; Van Belle P; Poolman JT; Vandepapelière P; Horsmans Y
    Vaccine; 2015 Jan; 33(4):577-84. PubMed ID: 24176494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of adsorbed antigen in mono-valent and combination vaccines.
    Morefield GL; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2004 May; 22(15-16):1973-84. PubMed ID: 15121310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis.
    He F; Woods CE; Trilisky E; Bower KM; Litowski JR; Kerwin BA; Becker GW; Narhi LO; Razinkov VI
    J Pharm Sci; 2011 Apr; 100(4):1330-40. PubMed ID: 24081468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting alum-protein interactions.
    Huang M; Wang W
    Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of adjuvant in mediating antigen structure and stability.
    Braun LJ; Eldridge AM; Cummiskey J; Arthur KK; Wuttke DS
    J Pharm Sci; 2012 Apr; 101(4):1391-9. PubMed ID: 22213631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
    Bologa M; Kamtchoua T; Hopfer R; Sheng X; Hicks B; Bixler G; Hou V; Pehlic V; Yuan T; Gurunathan S
    Vaccine; 2012 Dec; 30(52):7461-8. PubMed ID: 23123106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved Fluorescence Methods for High-Throughput Protein Formulation Screening.
    Wei Y; Larson NR; Angalakurthi SK; Russell Middaugh C
    SLAS Technol; 2018 Dec; 23(6):516-528. PubMed ID: 29884102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of a high-throughput relative chemical stability assay to screen therapeutic protein formulations by assessment of conformational stability and correlation to aggregation propensity.
    Rizzo JM; Shi S; Li Y; Semple A; Esposito JJ; Yu S; Richardson D; Antochshuk V; Shameem M
    J Pharm Sci; 2015 May; 104(5):1632-40. PubMed ID: 25757872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
    Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid.
    Jiang D; Morefield GL; HogenEsch H; Hem SL
    Vaccine; 2006 Mar; 24(10):1665-9. PubMed ID: 16246468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of multivalent pneumococcal conjugate vaccines.
    Katkocin DM
    Dev Biol (Basel); 2000; 103():113-9. PubMed ID: 11214230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of vaccine stability.
    Volkin DB; Burke CJ; Sanyal G; Middaugh CR
    Dev Biol Stand; 1996; 87():135-42. PubMed ID: 8854010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.
    Solanki VA; Jain NK; Roy I
    Int J Pharm; 2012 Feb; 423(2):297-302. PubMed ID: 22155287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput analysis of protein stability in polyanhydride nanoparticles.
    Petersen LK; Sackett CK; Narasimhan B
    Acta Biomater; 2010 Oct; 6(10):3873-81. PubMed ID: 20388561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.
    Dasnoy S; Dezutter N; Lemoine D; Le Bras V; Préat V
    Pharm Res; 2011 Jul; 28(7):1591-605. PubMed ID: 21400018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of aluminium-containing adjuvants.
    White JL; Hem SL
    Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.
    McClure SM; Ahl PL; Blue JT
    Pharm Res; 2018 Mar; 35(4):81. PubMed ID: 29508082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of immobilization onto aluminum hydroxide particles on the thermally induced conformational behavior of three model proteins.
    Bai S; Dong A
    Int J Biol Macromol; 2009 Jul; 45(1):80-5. PubMed ID: 19397921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.